MetroHealth Integrates Virtual Behavioral Health With Primary Care
Virtual-first partner company Ovatient was formed through a partnership between MetroHealth and South Carolina-based MUSC Health in October 2022
Virtual-first partner company Ovatient was formed through a partnership between MetroHealth and South Carolina-based MUSC Health in October 2022
By addressing each community’s unique needs with tailored, culturally responsive care and cross-sector collaboration, we can empower healthcare providers to drive lasting, equitable outcomes. The post Closing America’s Diabetes Divide: A $412 Billion Opportunity to Transform Diabetes Care appeared first on MedCity News.
Do you have feedback about the “Silence in Sikeston” project that you’d like to share with KFF Health News? We want to hear from you. Share your thoughts, feelings, and questions about our “Silence in Sikeston” project here. (Fewer than 300 words, please.)(Required)Do you want to break the silence about an issue in your community?…
If you or someone you know may be experiencing a mental health crisis, contact the 988 Suicide & Crisis Lifeline by dialing or texting “988.” BIRMINGHAM, Ala. — Frank Wampol had a dark realization when he came across some alarming data a few years ago: Over 5,000 male construction workers die from suicide annually —…
This analysis examines the recent growth of Medicare Advantage as a share of hospital inpatient days. Medicare Advantage rose from 13% to 25% of all inpatient days from 2015 to 2023, although there was wide variation among hospitals.
AI doesn’t need to be a black box — and hospitals don’t need to invest based on blind faith. With the right structure, questions, and metrics in place, healthcare leaders can cut through the hype and make decisions that actually drive value. The post Hospitals Are Investing in AI — How Can They Evaluate ROI?…
Polysight launches its platform with a pilot at 11-hospital Wellstar Health System
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…
We should never wait for tragedies to force a conversation around clear governance and accountability. Oversight has to evolve alongside innovation to protect people before harm occurs. The post When Innovation Outpaces Oversight: Lessons from IV Spas to AI appeared first on MedCity News.
Romvimza, a drug for treating tenosynovial giant cell tumor, was initially developed by Deciphera Pharmaceuticals. Last year, Ono Pharmaceutical acquired Deciphera to build up its oncology portfolio and expand its business prospects in the U.S. and Europe. The post Ono Pharma Drug Acquired in $2.4B Deal Wins FDA Approval for Treating Rare Type of Tumor…